JP2003527342A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003527342A5 JP2003527342A5 JP2001539455A JP2001539455A JP2003527342A5 JP 2003527342 A5 JP2003527342 A5 JP 2003527342A5 JP 2001539455 A JP2001539455 A JP 2001539455A JP 2001539455 A JP2001539455 A JP 2001539455A JP 2003527342 A5 JP2003527342 A5 JP 2003527342A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- glucocorticoid receptor
- receptor antagonist
- administration
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16743299P | 1999-11-23 | 1999-11-23 | |
| US60/167,432 | 1999-11-23 | ||
| PCT/US2000/032260 WO2001037840A1 (en) | 1999-11-23 | 2000-11-21 | Methods for treating mild cognitive impairment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003527342A JP2003527342A (ja) | 2003-09-16 |
| JP2003527342A5 true JP2003527342A5 (enExample) | 2007-11-29 |
Family
ID=22607362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001539455A Pending JP2003527342A (ja) | 1999-11-23 | 2000-11-21 | 軽度認知障害を処置する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US6620802B1 (enExample) |
| EP (1) | EP1242094A4 (enExample) |
| JP (1) | JP2003527342A (enExample) |
| AU (1) | AU778090B2 (enExample) |
| CA (1) | CA2389570C (enExample) |
| HK (1) | HK1047050A1 (enExample) |
| WO (1) | WO2001037840A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010046470A1 (en) * | 2000-05-10 | 2001-11-29 | Kieko Morita | Diagnoses and treatment of disorders using an alternative glucose pathway |
| CN1556709A (zh) | 2001-03-23 | 2004-12-22 | �Ƹ��� | 使用糖皮质激素受体特效拮抗剂治疗压力症的方法 |
| MXPA04001893A (es) | 2001-08-31 | 2005-03-07 | Corcept Therapeutics Inc | Metodos para inhibir deterioro cognoscitivo en adultos con sindrome de down. |
| WO2003086410A1 (en) * | 2002-04-05 | 2003-10-23 | The University Of Edinburgh | Pharmaceutical compositions comprising a 11-beta hydroxysteroid dehydrogenase inhibitor and a diuretic agent |
| US8237946B2 (en) * | 2004-10-08 | 2012-08-07 | Sharp Laboratories Of America, Inc. | Methods and systems for imaging device accounting server redundancy |
| US20090156565A1 (en) * | 2004-12-03 | 2009-06-18 | The Children's Hospital Of Philadelphia | Composition and use thereof in enhancing a therapeutic effect of an antiepileptic drug |
| ES2865504T3 (es) * | 2008-10-16 | 2021-10-15 | Univ Johns Hopkins | Procedimientos y composiciones para la mejora de la función cognitiva |
| US20110202284A1 (en) * | 2010-02-10 | 2011-08-18 | Mcreynolds Cristopher | Novel groups of biomarkers for diagnosing alzheimer's disease |
| US10500216B2 (en) | 2011-11-18 | 2019-12-10 | Corcept Therapeutics, Inc. | Optimizing mifepristone absorption |
| US20150290158A1 (en) * | 2012-11-09 | 2015-10-15 | Elliott C. Lasser | X-ray contrast media compositions and methods of using the same to treat, reduce or delay the onset of cns inflammation and inflammation associated conditions |
| US10154988B2 (en) | 2012-11-14 | 2018-12-18 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
| US10806717B2 (en) | 2013-03-15 | 2020-10-20 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| JP6433482B2 (ja) | 2013-03-15 | 2018-12-05 | エージンバイオ， インコーポレイテッド | 認知機能を改善するための方法および組成物 |
| US9943526B2 (en) | 2015-04-21 | 2018-04-17 | Corcept Therapeutics, Inc. | Optimizing mifepristone levels for cushing's patients |
| AU2016268096B2 (en) | 2015-05-22 | 2021-04-01 | Agenebio, Inc. | Extended release pharmaceutical compositions of levetiracetam |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3337450A1 (de) * | 1983-10-12 | 1985-04-25 | Schering AG, 1000 Berlin und 4709 Bergkamen | Prostaglandine und antigestagene fuer den schwangerschaftsabbruch |
| CA2250874A1 (en) | 1996-04-09 | 1997-10-16 | Btg International Limited | Use of 7 alpha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders |
| CN1528315A (zh) * | 1997-10-06 | 2004-09-15 | ������˹̹�������ѧ�й�ίԱ�� | 治疗糖皮质素功能失调相关性精神病的方法 |
| CN1130200C (zh) | 1998-05-15 | 2003-12-10 | 利兰·斯坦福青年大学托管委员会 | 用于治疗痴呆的糖皮质激素受体拮抗剂 |
-
2000
- 2000-11-20 US US09/717,703 patent/US6620802B1/en not_active Expired - Lifetime
- 2000-11-21 AU AU19283/01A patent/AU778090B2/en not_active Expired
- 2000-11-21 CA CA2389570A patent/CA2389570C/en not_active Expired - Lifetime
- 2000-11-21 JP JP2001539455A patent/JP2003527342A/ja active Pending
- 2000-11-21 EP EP00982226A patent/EP1242094A4/en not_active Ceased
- 2000-11-21 WO PCT/US2000/032260 patent/WO2001037840A1/en not_active Ceased
- 2000-11-21 HK HK02108738.8A patent/HK1047050A1/zh unknown
-
2003
- 2003-07-28 US US10/628,724 patent/US20040019028A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003527342A5 (enExample) | ||
| AU747956B2 (en) | Methods for treating psychosis associated with glucocorticoid related dysfunction | |
| JP2003505336A5 (enExample) | ||
| JP2001518509A5 (enExample) | ||
| AU726091B2 (en) | Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen | |
| CA2440605A1 (en) | Methods for treating stress disorders using glucocorticoid receptor-specific antagonists | |
| CA2389570A1 (en) | Methods for treating mild cognitive impairment | |
| CA2454339A1 (en) | Methods for preventing antipsychotic-induced weight gain | |
| JP2006508951A5 (enExample) | ||
| CA2504697A1 (en) | Methods for treating migraine | |
| JP2006507311A5 (enExample) | ||
| JP2005535664A5 (enExample) | ||
| CA2459033A1 (en) | Methods for inhibiting cognitive deterioration in adults with down's syndrome | |
| JPH07278017A (ja) | 麻薬又は麻薬混合物からの自然の又は早められた退薬症状と関連した徴候を予防し又は治療するための薬剤の製造への抗グルココルチコイド活性を有する化合物の使用及びそれらを含有する組成物 | |
| EP0921804B1 (en) | Biphasic oral contraceptive method and kit comprising a combination of a progestin and estrogen | |
| Baulieu | A novel approach to human fertility control: contragestion by the anti-progesterone RU 486 | |
| Guarderas | Rhinitis and sinusitis: office management | |
| JP2005512949A5 (enExample) | ||
| CA2532594A1 (en) | Antiglucocorticoids for the treatment of catatonia | |
| CA2446506A1 (en) | Methods for treating delirium using glucocorticoid receptor-specific antagonists | |
| Mazer | Omalizumab reduced inhaled corticosteroid use and exacerbations in childhood allergic asthma | |
| EP1726307A2 (en) | Methods for treating psychosis associated with glucocorticoid related dysfunction | |
| HK1062533B (en) | Methods for inhibiting cognitive deterioration in adults with down's syndrome | |
| AU2002335678A1 (en) | Methods for inhibiting cognitive deterioration in adults with down's syndrome | |
| HK1022843B (en) | Monophasic oral contraceptive method and kit comprising a combination of progestin and estrogen |